Where does Alan Crane work?

Alan Crane is Executive Chairman & Cofounder, Polaris Entrepreneur Partner of Dyno Therapeutics and Entrepreneur Partner at Polaris Partners and Board director at Pandion Therapeutics and Board director at Pandion Therapeutics.

What does Alan Crane invest in?

Alan Crane invests in Biotech, Digital Health, Healthtech.

What companies did Alan Crane found?

Alan Crane founded Dyno Therapeutics.

What boards does Alan Crane sit on?

Alan Crane holds tracked board seats at Dare Bioscience, Navitor Pharmaceuticals, Pandion Therapeutics, Pandion Therapeutics, Seismic Therapeutic, Seventh Sense Biosystems, Vaccinex, XTuit Pharmaceuticals.

What companies has Alan Crane invested in?

Investments tracked here include Adnexus Therapeutics, Arsia Therapeutics, Dyno Therapeutics, KSQ Therapeutics, Momenta Pharmaceuticals, Navitor Pharmaceuticals, Ocular Therapeutix, Pandion Therapeutics, Seismic Therapeutic, Sirtris Pharmaceuticals, T2 Biosystems, Visterra, and 1 more.

Alan Crane

InvestorFounder

Entrepreneur Partner at Polaris Partners · Executive Chairman & Cofounder, Polaris Entrepreneur Partner at Dyno Therapeutics · Board director at Pandion Therapeutics

FoundedDyno Therapeutics

About

Alan Crane joined Polaris Partners in 2002 as an entrepreneur partner, focusing on building and investing in healthcare companies. He has held founder, CEO, and Chairman roles across ten Polaris companies, including co-founding Zag Bio, Seismic Therapeutic, and Dyno Therapeutics, and founding Pandion Therapeutics (acquired by Merck). He was previously president and CEO of Momenta Pharmaceuticals (acquired by J&J) and SVP of corporate development at Millennium Pharmaceuticals, and holds degrees from Harvard College, Harvard Graduate School of Arts & Sciences, and Harvard Business School.

Contact· self-published, not guessed

a•••@polarispartners.comreveal

Likely email· guessed from name + firm domain, not firm-published

a•••@polarispartners.comreveal100% confident

Invests in

BiotechDigital HealthHealthtech

Executive Chairman & Cofounder, Polaris Entrepreneur Partner at Dyno Therapeutics

Intro paths

→

In turn, Alan can intro founders to Dyno Therapeutics's investors below.

Dyno Therapeutics's investors · 9

Andreessen HorowitzMenlo Park · $500K – $50M checks Casdin CapitalNew York CRV (Charles River Ventures)Bay Area · $250K – $5M checks GENERAL INCEPTIONPalo Alto GV (Google Ventures)Mountain View · $250K – $50M checks KdT VenturesAustin · $500K – $3M checks Lux CapitalNew York · $100K – $100M checks Obvious VenturesSan Francisco · $250K – $6M checks Polaris PartnersBoston · $500K – $5M checks

Co-founders at Dyno Therapeutics

Eric KelsicCEO & Cofounder

Sam SinaiVice President, Head of ML & Cofounder

Adrian VeresChief Scientific Officer & Cofounder

George ChurchScientific Cofounder

Tomas BjorklundScientific Co-founder

Board director at Pandion Therapeutics

Intro paths

→

In turn, Alan can intro founders to Pandion Therapeutics's investors below.

Pandion Therapeutics's investors · 3

Access BiotechnologyNew York City · since 2018 Polaris PartnersBoston · $500K – $5M checks · since 2018 Versant VenturesSan Francisco · $250K – $5M checks · since 2018

Co-founders at Pandion Therapeutics

Jo VineyExecutive Officer

Board director at Pandion Therapeutics

Intro paths

→

In turn, Alan can intro founders to Pandion Therapeutics's investors below.

Pandion Therapeutics's investors · 3

Access BiotechnologyNew York City · since 2018 Polaris PartnersBoston · $500K – $5M checks · since 2018 Versant VenturesSan Francisco · $250K – $5M checks · since 2018

Co-founders at Pandion Therapeutics

Jo VineyExecutive Officer

Deals · 7

Seismic TherapeuticBoard seat

via Polaris Partners · filed Sep 2024 · $146.3M raise

Pandion TherapeuticsBoard seat

via Polaris Partners · filed Apr 2020 · $80M raise

Navitor PharmaceuticalsBoard seat

via Polaris Partners · filed Mar 2018 · $25M raise

Seventh Sense BiosystemsBoard seat

via Polaris Partners · filed Sep 2017 · $10M raise

VaccinexBoard seat

via Polaris Partners · filed Jul 2017 · $18.2M raise

Dare BioscienceBoard seat

via Polaris Partners · filed Oct 2016 · $1 raise

XTuit PharmaceuticalsBoard seat

via Polaris Partners · filed Sep 2016 · $22M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

Adnexus TherapeuticsArsia TherapeuticsDyno Therapeutics KSQ TherapeuticsMomenta PharmaceuticalsOcular TherapeutixSirtris PharmaceuticalsT2 BiosystemsVisterraZag Bio

Sources: SEC Form D filings · the firm's website.

Colleagues at Polaris Partners

Alexandra Cantley

Managing Partner at Polaris Partners

Alicia Taylor

Investment Director at Pembroke VCT

Amir Nashat

Entrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive roles

Amy Schulman

Managing Partner at Polaris Partners

Annie Wihongi

Executive Assistant and Office Manager at Polaris Partners

Brian Chee

Managing Partner at Polaris Partners

Brian Lewis

Director, Legal & Investment Analytics at Polaris Partners

Chen-Ee Lee

Partner at Polaris Partners

Network8

Alexandra Cantley

Managing Partner at Polaris Partners

Amy Schulman

Managing Partner at Polaris Partners

Brian Chee

Managing Partner at Polaris Partners

Darren Carroll

Partner at Polaris Partners

Dave Barrett

Senior Advisory Partner at Polaris Partners

Ellie McGuire

Managing Partner at Polaris Partners

Gary Swart

Operating Partner at Polaris Partners

Terry McGuire

Founding Partner at Polaris Partners

Investors connected to Alan in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alan Crane?: Alan Crane joined Polaris Partners in 2002 as an entrepreneur partner, focusing on building and investing in healthcare companies. He has held founder, CEO, and Chairman roles across ten Polaris companies, including co-founding Zag Bio, Seismic Therapeutic, and Dyno Therapeutics, and founding Pandion Therapeutics (acquired by Merck). He was previously president and CEO of Momenta Pharmaceuticals (acquired by J&J) and SVP of corporate development at Millennium Pharmaceuticals, and holds degrees from Harvard College, Harvard Graduate School of Arts & Sciences, and Harvard Business School.
Where does Alan Crane work?: Alan Crane is Executive Chairman & Cofounder, Polaris Entrepreneur Partner of Dyno Therapeutics and Entrepreneur Partner at Polaris Partners and Board director at Pandion Therapeutics and Board director at Pandion Therapeutics.
What does Alan Crane invest in?: Alan Crane invests in Biotech, Digital Health, Healthtech.
What companies did Alan Crane found?: Alan Crane founded Dyno Therapeutics.
What boards does Alan Crane sit on?: Alan Crane holds tracked board seats at Dare Bioscience, Navitor Pharmaceuticals, Pandion Therapeutics, Pandion Therapeutics, Seismic Therapeutic, Seventh Sense Biosystems, Vaccinex, XTuit Pharmaceuticals.
What companies has Alan Crane invested in?: Investments tracked here include Adnexus Therapeutics, Arsia Therapeutics, Dyno Therapeutics, KSQ Therapeutics, Momenta Pharmaceuticals, Navitor Pharmaceuticals, Ocular Therapeutix, Pandion Therapeutics, Seismic Therapeutic, Sirtris Pharmaceuticals, T2 Biosystems, Visterra, and 1 more.